In SITG30-treated animals, plasma insulin levels increased to 4.153 ± 0.174, which exceeded the control value but did not reach statistical significance compared to the control group. 3.4.
← all excerpts
In Vivo and Computational Studies on Sitagliptin's Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer's Disease.
1
—
—